Industry Events at #ASBRS23

Program Objectives

• Review the wealth of data on the Oncotype DX Breast Recurrence Score® test in pre- and postmenopausal patients
• Interrogate current controversies at the intersection of genomic testing with patient menopausal status, local regional recurrence, and clinicopathologic features
• Discuss how guidelines have been informed by TAILORx and RxPONDER trials

Speakers

• Tari King, MD, Chief, Breast Surgery, Dana Farber/Brigham and Women's Hospital
• Christy Russell, MD, Vice President, Medical Affairs, Exact Sciences
• Jennifer Racz, MD, Director, Medical Affairs, Oncology, Exact Sciences

For More Information

For more information, visit www.OncotypeIQ.com.

Program Objectives

Join Dr. Beth DuPree and Dr. William Scarlett for an educational symposium on pushing the limit with patient selection and techniques for nipple sparing mastectomies. During this program, our faculty will discuss the previously radiated patient, address the ptotic breast and touch on nerve grafting, while maintaining safety as our priority.

For More Information

Overview

In this interactive hands-on workshop, participants will learn about optimizing analgesia during breast procedures with a focus on ultrasound-guided pectoralis (PECS) blocks, serratus plane blocks, and erector spinae plane (ESP) blocks. Participants will learn the indications, benefits, technical tips and evidence supporting the performance of these analgesic techniques.

Program Objectives

• Explain the rationale for optimizing pain control patients undergoing surgery for breast cancer, and the impact of uncontrolled postoperative pain
• Define the goals of multimodal analgesia and the relative value of techniques that employ local anesthetics
• Discuss the benefits of opioid-sparing treatment regimens in the care of patients experiencing post-surgical pain
• Apply best practices pertaining to the administration of local anesthetics during breast cancer surgery by both the surgeon and anesthesiologist

For More Information

Overview

SCOUT® Radar localization exclusively spans the care continuum from time of biopsy placement to targeted axillary dissection to excellent surgical outcomes. Discover the state-of-the art localization techniques practiced by key opinion leaders from around the country. Learn how recent product innovations enable placing SCOUT under MRI guidance, future platform enhancements and the clinical and economic rationale for placing SCOUT at Time of Biopsy, providing a better patient experience, and streamlining workflow.

Overview

View the replay of this educational session at the American Society of Breast Surgeons' 2023 Annual Meeting on how Perimeter’s margin visualization technology gives surgeons the real-time insights they need to personalize clinical decisions at the point of care.

Overview

Localization technology continues to evolve. Hear comparisons among localization options, from wire-based to wire-free guidance, including the impacts of these options on the patient experience, and on workflow and scheduling optimization for both the OR and radiology. Join Dr. Valerie Gorman as she shares her perspective and experiences through an in-depth review of clinical cases.

Program Objectives

• Discuss the advantages and disadvantages of wire vs wire-free breast tumor localization for surgical guidance
• Describe techniques for wire-free localization in the breast
• Explain the use of wire-free localization and neoadjuvant treatment
• Understand the impact of wire-free localization on oncoplastic breast surgery techniques

For More Information

Contact customer support at World Class CME, office@worldclasscme.com, 980-819-5095.

Overview

Clarix Imaging sponsored their inaugural symposium at ASBrS which was met with overwhelming success. The program featured five pioneering breast surgical oncologists sharing their experience using the Clarix Imaging’s Volumetric Specimen Imaging system (VSI-360™), the only specimen CT system allowing real-time, true 3D visualization of specimens intraoperatively.

The audience had a high level of engagement, was excited about the technology, and asked about joining the community of true 3D specimen imaging. The team looks forward to collaborating with surgeons to bring evidence-based innovative solutions which improve the standard of care for breast cancer patients throughout the world.

Overview

See how surgeons around the world are using a single platform to achieve optimal clinical results while tailoring treatments for their patients. Enjoy hands-on experience with devices from biopsy to surgery and see what new technologies are on the horizon.

Faculty

• Michael Alvarado, MD, University of California San Francisco
• Kandace P. McGuire, MD, Virginia Commonwealth University
• Eirini Pantiora, MD, Uppsala University Hospital, Sweden
• Rhiana Menen, MD, St. Luke’s, Idaho

Agenda

• Evidence-Based Decisions: What Will You Decide?
• Changing the Standard: The Evolution of Magtrace®
• Clinical Roundup: Thinking Global
• Ready, Set, Action! The Future of Magnetic Localization

For More Information

For more information, visit www.mammotome.com.